Lung cancer trials in Guatemala

1 trial · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)

  Where

  Guatemala City

  Age

  18 years and over

  People

  675 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT07190248 · EU 2024-514500-14-00